Why the study?
Does transcatheter edge-to-edge repair (TEER) compare favorably in efficacy and safety to surgical mitral valve repair in adults with primary degenerative mitral regurgitation?
Does transcatheter edge-to-edge repair (TEER) compare favorably in efficacy and safety to surgical mitral valve repair in adults with primary degenerative mitral regurgitation?
In primary degenerative mitral regurgitation, surgical repair provides more complete and durable correction, while TEER offers superior procedural safety (fewer transfusions, less new-onset AF, shorter hospital stay) for patients at higher surgical risk.
Answers are grounded in this paper and cite their sources.
Supports surgical repair for durable correction in operable patients; extends safety data favoring TEER in higher-risk primary MR.
To compare transcatheter edge-to-edge repair (TEER) with surgical mitral valve repair in adults with primary degenerative mitral regurgitation (DMR). PubMed/MEDLINE, Embase, Ovid MEDLINE, Scopus and ClinicalTrials.gov were searched to 23 October 2025 (PROSPERO CRD420251153452). The primary analysis included studies of DMR with a surgical repair comparator; cohorts with a predominantly replacement comparator and administrative registries entered separate sensitivity analyses. Odds ratios (OR) were pooled with the Mantel-Haenszel method, with random-effects models as sensitivity analyses. Certainty was rated with GRADE. Nine studies were included; five (775 patients) formed the primary analysis. TEER was associated with more residual mitral regurgitation of at least moderate grade (OR 8.21, 95% CI 4.56-14.79) and more mitral reinterventions (OR 4.10, 1.69-9.94), and with fewer transfusions (OR 0.11, 0.05-0.23), less new-onset atrial fibrillation (OR 0.09, 0.03-0.28) and a shorter hospital stay (random-effects mean difference -3.6 days, -6.2 to -1.0). Early mortality did not differ significantly (OR 2.03, 0.62-6.61; 12 deaths), but the interval was too wide to establish equivalence. Four of the five primary studies ended enrolment before 2018. Certainty was low to very low. Surgical repair remains the reference treatment for patients with favourable operative risk and repairable anatomy. TEER is a valuable alternative for carefully selected patients in whom procedural safety or surgical risk predominates, at the cost of less complete and less durable correction. The absence of a significant difference in early mortality does not demonstrate equivalence.
No takes yet. Share an insight, caveat, or question.
Barrientos et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: